POLYCYTHEMIA VERA (PV)
Clinical trials for POLYCYTHEMIA VERA (PV) explained in plain language.
Never miss a new study
Get alerted when new POLYCYTHEMIA VERA (PV) trials appear
Sign up with your email to follow new studies for POLYCYTHEMIA VERA (PV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill-and-shot combo aims to tame overactive blood production in rare disease
Disease control Not yet recruitingThis study tests whether a new pill (gecacitinib) plus a standard injection (pegylated interferon) can safely bring blood counts back to normal in people with polycythemia vera, a condition where the body makes too many red blood cells. Thirty adults will receive the combination …
Matched conditions: POLYCYTHEMIA VERA (PV)
Phase: NA • Sponsor: Duan Minghui • Aim: Disease control
Last updated May 26, 2026 05:47 UTC
-
New drug ZE74-0282 targets rare blood cancers in early trial
Disease control Not yet recruitingThis early-phase study tests an experimental drug, ZE74-0282, in about 60 adults with polycythemia vera or myelofibrosis caused by a JAK2 V617F mutation. The main goals are to find the safest dose and see if the drug shows signs of fighting the disease. Participants will take the…
Matched conditions: POLYCYTHEMIA VERA (PV)
Phase: PHASE1 • Sponsor: Eilean Therapeutics • Aim: Disease control
Last updated May 26, 2026 05:45 UTC
-
Scientists investigate why polycythemia vera patients struggle to exercise
Knowledge-focused Not yet recruitingThis study looks at why people with polycythemia vera, a rare blood disorder, have trouble exercising. Researchers will measure blood thickness and oxygen levels during exercise tests in 54 patients. The goal is to understand the causes of exercise intolerance to help tailor phys…
Matched conditions: POLYCYTHEMIA VERA (PV)
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated May 18, 2026 12:06 UTC